Status:
UNKNOWN
Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection
Lead Sponsor:
Phramongkutklao College of Medicine and Hospital
Collaborating Sponsors:
Silpakorn University
Conditions:
Peritoneal Dialysis-related Infection
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis catheter removal or patient death. The present study aimed to investigate peritoneal dialysis-related infectio...
Eligibility Criteria
Inclusion
- Age greater than or equal to 20 years
- End stage renal disease patients on peritoneal dialysis follow up at Phramongkutklao hospital's peritoneal dialysis clinic between January 1, 2021 to March 31, 2023
- Start peritoneal dialysis or follow up at Phramongkutklao hospital's peritoneal dialysis clinic at least 90 days before recruited
- Use topical mupirocin ointment for prevention of peritoneal dialysis-related infection between January 1, 2021 to December 31, 2021
- Can be used LINE application throughout the study
Exclusion
- Allergy to gentamicin or components
- Previous systemic antibiotics use within 90 days before recruited
- Previous peritoneal dialysis-related infection within 28 days before recruited
- Immunosuppressants used
- Prospective follow up less than 2 months
- Don't sign informed consent
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05251584
Start Date
December 1 2021
End Date
May 31 2023
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phramongkutklao Hospital
Ratchathewi, Bangkok, Thailand, 10400